TrialCancer immunology, immunotherapy : CII2022

Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy.

Yasuhiro Nagata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.